PMID- 38128176 OWN - NLM STAT- MEDLINE DCOM- 20240112 LR - 20240112 IS - 1532-866X (Electronic) IS - 0049-0172 (Linking) VI - 64 DP - 2024 Feb TI - Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort. PG - 152353 LID - S0049-0172(23)00195-6 [pii] LID - 10.1016/j.semarthrit.2023.152353 [doi] AB - OBJECTIVES: To evaluate the association between health-related quality of life (HRQoL) and mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). METHODS: We searched patients with AAV assessed for HRQoL at initial diagnosis using Short Form 36 (SF-36). Relationships between SF-36 physical component summary (PCS) and mental component summary (MCS) scales and variables were estimated using Pearson's correlation analysis. Contal's and O'Quigley's methods were used to determine optimal SF-36 PCS cut-off for predicting all-cause mortality. The Cox proportional hazards model and inverse probability of treatment weighting (IPTW) analysis were used to ascertain prognostic implications of SF-36 scales and mortality. RESULTS: The median SF-36 PCS and MCS values of the 189 patients were 47.5 and 53.3, respectively, and 21 (11.1%) patients (microscopic polyangiitis [MPA], n=15; granulomatosis with polyangiitis [GPA], n=6) died during follow-up. SF-36 PCS was significantly but weakly associated with Birmingham Vasculitis Activity Score, Five-factor score, erythrocyte sedimentation rate (ESR), and C-reactive protein. However, SF-36 MCS was not associated with ESR. In the multivariable Cox analysis, a decrease of SF-36 PCS score by one unit indicated a higher death risk (hazard ratio [HR]: 1.030; 95% confidence interval [CI]: 1.007, 1.052; p=0.041), which was not for SF-36 MCS. IPTW analysis in a subgroup of MPA and GPA patients revealed increased patient mortality with SF-36 PCS <53.75 independently (HR: 3.249; 95% CI: 1.169, 9.033; p=0.024). CONCLUSION: Poor baseline physical functioning associated with premature death in patients with MPA and GPA. HRQoL assessment during initial diagnosis may provide clinical insights for this population. CI - Copyright (c) 2023. Published by Elsevier Inc. FAU - Ahn, Sung Soo AU - Ahn SS AD - Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea. FAU - Heo, Seok-Jae AU - Heo SJ AD - Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea. FAU - Ha, Jang Woo AU - Ha JW AD - Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea. FAU - Park, Yong-Beom AU - Park YB AD - Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea. FAU - Lee, Sang-Won AU - Lee SW AD - Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: sangwonlee@yuhs.ac. LA - eng PT - Journal Article DEP - 20231216 PL - United States TA - Semin Arthritis Rheum JT - Seminars in arthritis and rheumatism JID - 1306053 RN - 0 (Antibodies, Antineutrophil Cytoplasmic) SB - IM MH - Humans MH - *Granulomatosis with Polyangiitis/diagnosis MH - Antibodies, Antineutrophil Cytoplasmic MH - Quality of Life MH - *Microscopic Polyangiitis MH - Prognosis MH - *Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis OTO - NOTNLM OT - Health-related quality of life OT - SF-36 OT - antineutrophil cytoplasmic antibody OT - mortality OT - vasculitis COIS- Declaration of Competing Interest The authors declare that no competing interests exist. EDAT- 2023/12/22 00:42 MHDA- 2024/01/12 06:42 CRDT- 2023/12/21 18:00 PHST- 2023/08/14 00:00 [received] PHST- 2023/10/27 00:00 [revised] PHST- 2023/12/13 00:00 [accepted] PHST- 2024/01/12 06:42 [medline] PHST- 2023/12/22 00:42 [pubmed] PHST- 2023/12/21 18:00 [entrez] AID - S0049-0172(23)00195-6 [pii] AID - 10.1016/j.semarthrit.2023.152353 [doi] PST - ppublish SO - Semin Arthritis Rheum. 2024 Feb;64:152353. doi: 10.1016/j.semarthrit.2023.152353. Epub 2023 Dec 16.